Insulin pump technology that automatically adjusts background insulin every 5 minutes based on a body’s unique needs.*
For people with type 1 diabetes ages 7 and up.MiniMedTM 670G System
Here are some of the benefits people can experience when using the MiniMed™ 670G system.
The system automatically changes the amount of background insulin you receive based on your body’s needs.
The system allows you to deliver insulin through a small tube that is hidden under your clothing, rather than manual injections.
With the push of a button, you can give yourself insulin.
HELP KEEP GLUCOSE LEVELS IN RANGE WITH OUR MOST ADVANCED SMARTGUARD™ TECHNOLOGY
Waterproof pump, protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours.¶
The pump dimensions in inches are approximately 2.1 width x 3.78 length x 0.96 depth. The weight of the pump is approximately 3 ounces.
The MiniMed™ 670G insulin pump system is designed to withstand most conditions encountered in your daily life. Pump storage temperature range is from -4 °F (-20 °C) to 122 °F (50 °C). Air pressure range is from 700 hPa to 1060 hPa (10.2 psi to 15.4 psi).
At any time the user can review 90 days of pump history.
Medtronic Diabetes provides a variety of infusion sets to fit your needs.
Used with your pump for Continuous Glucose Monitoring (CGM). A device that connects to a glucose sensor. The transmitter collects data measured by the sensor and wirelessly sends this data to monitoring devices.
Standard: 1.5 units/minute
Quick: 15 units/minute
0.025 units, 0.05 units, 0.1 units
Altitude Range Pump operating range is from 10.2 psiA (70.33 kPa) to 15.4 psiA (106.18 kPa). Storage range is from 7.2 psiA (49.64 kPa) to 15.4 psiA (106.18 kPa).
- LED (Light-emitting Diode)
- Time out: 15 seconds (default), 30 seconds, one minute, three minutes
- Time out when battery is low: 15 seconds (default), 30 seconds
0 to 35 units per hour or the Max Basal Rate amount, whichever is lower.
Used with the pump for CGM. The sensor is a small part of the continuous glucose monitoring system inserted just below the skin to measure glucose levels in the interstitial fluid.
Used to upload system data to the diabetes management software using a USB port on your computer.
The serter is used as an aid for inserting the sensor. It is indicated for single-patient use and is not intended for multiple patient use.
The pump requires one new AA (1.5 V) battery. For best results, use a new AA lithium (FR6) battery. The pump also accepts an AA alkaline (LR6) or a fully charged AA NiMH (HR6) nickel-metal hydride rechargeable battery.
Medtronic reservoir MMT-332A, 3.0 ml (300-unit).
The MiniMed™ 670G system comes with a compatible meter. It wirelessly connects to your pump, allowing you to send BG meter readings to your pump.
Refers to SmartGuard™ Auto Mode feature; The MiniMed™ 670G system can automatically increase or decrease insulin delivery based on continuous glucose monitoring (CGM) values; however, the user must still administer meal boluses. ADA recommendation for a glucose range is 80-180 mg/dL in non-pregnant adults with diabetes. Based on clinical study data in pivotal trial. Individual results may vary.
Based on sensor glucose.
Approved for ages 14 and older.
Refers to AutoMode. Some interaction required. Individual results may vary.
Arm sensor insertion site, 3-4 calibrations/day. Approved for ages 14-75 years.
At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM readings may not be transmitted from the CGM to the pump while in water.
Gopalakrishnan S, Mueckler J, Fogel C. The MiniMed™ 670G hybrid closed loop system & patient reported outcomes concerning quality of life measures (n=2.S34). Poster #963-P presented at the 78th Scientific Sessions of the American Diabetes Association: 2018 June 22 26, Orlando, Florida, USA.
Bergenstal R, Garg S, Weinzimer S, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407-1408
dQ&A Patient Panel. [Q4 2016 Summary Report]. dQ&A 2017.
Important Safety Information: MiniMed™ 670G System
The Medtronic MiniMed™ 670G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons, seven years of age and older, requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 670G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on Continuous Glucose Monitor sensor glucose values and can suspend delivery of insulin when the sensor glucose value falls below or is predicted to fall below predefined threshold values. The system requires a prescription. The Guardian™ Sensor (3) glucose values are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. A confirmatory finger stick test via the CONTOUR®NEXT LINK 2.4 blood glucose meter is required prior to making adjustments to diabetes therapy. All therapy adjustments should be based on measurements obtained using the CONTOUR®NEXT LINK 2.4 blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the CONTOUR®NEXT LINK 2.4 blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an Alternative Site (palm) or from a control solution test. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise. If a control solution test is out of range, please note that the result may be transmitted to your pump when in the “Always” send mode.
Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 670G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-670g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library
The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.
© 2020 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.
Ascensia, the Ascensia Diabetes Care logo, and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care.